Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 9/2011

01-09-2011 | Educational Series/Blue Sries

Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention

Authors: María Sereno, Cristina Aguayo, Carmen Guillén Ponce, César Gómez-Raposo, Francisco Zambrana, Miriam Gómez-López, Enrique Casado

Published in: Clinical and Translational Oncology | Issue 9/2011

Login to get access
Metadata
Title
Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention
Authors
María Sereno
Cristina Aguayo
Carmen Guillén Ponce
César Gómez-Raposo
Francisco Zambrana
Miriam Gómez-López
Enrique Casado
Publication date
01-09-2011
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 9/2011
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-011-0705-y

Other articles of this Issue 9/2011

Clinical and Translational Oncology 9/2011 Go to the issue

Educational Series/Red Series

Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics

Educational Series/Green Series

Mesenchymal niches of bone marrow in cancer

Educational Series/Yellow Series

Multidisciplinary approach in stage III non-small-cell lung cancer: standard of care and open questions

Research Articles

Multimodal therapy for adult Wilms’ tumour: an experience from one centre

Editorial

HER2 in gastric cancer: a biomarker with clinical impact, but not without translational challenges

Research Articles

Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits